ROBERT PHARES: Open Payments
NPI 1083666598 · OAKLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$53 in 3 payments from 3 companies in 2025. Trend: 2023 $30 · 2024 $84 · 2025 $53
Food & beverage: $53
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $20 |
| Boston Scientific Corporation | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: TRELEGY ELLIPTA, WATCHMAN FLX, XIFAXAN.
Industry payments across MD — which companies pay providers there.
